SG3376 is an antibody-drug conjugate (ADC) targeting human epidermal growth factor receptor 2 (HER2). SG3376 is promising for research of HER2-overexpressing cancers (e.g., breast, gastric cancer)[1].
Molecular Weight:
1070.15
CAS Number:
[2139261-06-4]
Formula:
C57H63N7O14
Target:
Drug-Linker Conjugates for ADC,EGFR
Application Notes:
MCE Product type: ADC Related
* VAT and and shipping costs not included. Errors and price changes excepted